3Wise, J. NICE guidance on depression: 35 organisations demand ‘full and proper revision’. BMJ 2019; 365: I2356.
4McPherson, S. A NICE game of Minecraft: philosophical flaws underpinning UK depression guideline methodology. Med Humanit 2019, in press.
5Gueorguieva, R, Chekroud, A, Krystal, J. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder : an individual patient-level data meta-analysis. Lancet Psychiatry 2017; 4: 230–7.
6Andrews, P, Kornstein, S, Halberstadt, C, Gardener, C, Neale, M. Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol 2011; 2: 159.
7El-Mallakh, R, Briscoe, B. Studies of long-term use of antidepressants: how should the data from them be interpreted? CNS Drugs 2012; 26: 97–109.
8Fava, GA, Offidani, E. The mechanisms of tolerance in antidepressant action. Prog Neuro Psychopharmacol Biol Psychiatry 2011; 35: 1593–602.
9Cohen, D, Recalt, AM. Discontinuing psychotropic drugs from participants in randomized controlled trials: a systematic review. Psychother Psychosom 2019; 88: 96–104.
10Hengartner, MP, Angst, J, Rossler, W. Antidepressant use prospectively relates to a poorer long-term outcome of depression: results from a prospective community cohort study over 30 years. Psychother Psychosom 2018; 87: 181–3.
11Bockting, CLH, ten Doesschate, MC, Spijker, J, Koeter, MWJ, Schene, AH. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosoms 2008; 77: 17–26.
12Groot, PC, van Os, J. Antidepressant tapering strips to help people come off medication more safely. Psychosis 2018; 10: 142–5.
13Fava, GA, Gatti, A, Belaise, C, Guidi, J, Offidani, E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84: 72–81.
14Read, J, Cartwright, C, Gibson, K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res 2014; 216: 67–73.
15Biesheuvel-Leliefeld, KE, Kok, GD, Bockting, CL, Cuijpers, P, Hollon, SD, van Marwijk, HW, et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression. J Affect Disord 2015; 174: 400–10.
16Karyotaki, E, Smit, Y, Holdt Henningsen, K, Huibers, MJ, Robays, J, de Beurs, D, et al. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. J Affect Disord 2016; 194: 144–52.
17Guidi, J, Tomba, E, Fava, GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry 2016; 173(2): 128–37.
18Kuyken, W, Warren, FC, Taylor, RS, Whalley, B, Crane, C, Bondolfi, G, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry 2016; 73(6): 565–74.
19Driessen, E, Van, HL, Don, FJ, Peen, J, Kool, S, Westra, D, et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry 2013; 170: 1041–50.
20Leuzinger-Bohleber, M, Hautzinger, M, Fiedler, G, Keller, W, Bahrke, U, Kallenbach, L, et al. Outcome of psychoanalytic and cognitive-behavioural long-term therapy with chronically depressed patients: a controlled trial with preferential and randomized allocation. Can J Psychiatry 2019; 64: 47–58.
21Steinert, C, Hofmann, M, Kruse, J, Leichsenring, F. Relapse rates after psychotherapy for depression - stable long-term effects? A meta-analysis. J Affect Disord 2014; 168: 107–18.
22Pigott, HE, Leventhal, AM, Alter, GS, Boren, JJ. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010; 79: 267–79.
23Hughes, S, Cohen, D. A systematic review of long term studies of drug treated and non-drug treated depression. J Affect Disord 2009; 118: 9–18.
24Paykel, ES, Scott, J, Teasdale, JD, Johnson, AL, Garland, A, Moore, R, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psych 1999; 56(9): 829–35.
25Valenstein, M, Pfeiffer, PN, Brandfon, S, Walters, H, Ganoczy, D, Kim, HM, et al. Augmenting ongoing depression care with a mutual peer support intervention versus self-help materials alone: a randomized trial. Psych Serv 2015; 67(2): 236–9.
26Hellerstein, DJ, Little, SA, Samstag, LW, Batchelder, S. Adding group psychotherapy to medication treatment in dysthymia. J Psychother Pract Res 2001; 10(2): 93.
27Browne, G, Steiner, M, Roberts, J, Gafni, A, Byrne, C, Dunn, E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Aff Dis 2002; 68(2): 317–30.
28Schramm, E, Zobel, I, Schoepf, D, Fangmeier, T, Schnell, K, Walter, H, et al. Cognitive behavioral analysis system of psychotherapy versus escitalopram in chronic major depression. Psychother Psychosom 2015; 84(4): 227–40.
29Schramm, E, Zobel, I, Dykierek, P, Kech, S, Brakemeier, EL, Külz, A, et al. Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study. J Aff Dis 2011; 129(1): 109–16.
30Wiles, N, Thomas, L, Abel, A, Ridgway, N, Turner, N, Campbell, J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet 2013; 381(9864): 375–84.
31Fonagy, P, Rost, F, Carlyle, JA, McPherson, S, Thomas, R, Pasco Fearon, RM, et al. Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry 2015; 14(3): 312–21.
32Chiesa, A, Castagner, V, Andrisano, C, Serretti, A, Mandelli, L, Porcelli, S, et al. Mindfulness-based cognitive therapy vs. psycho-education for patients with major depression who did not achieve remission following antidepressant treatment. Psychiatry Res 2015; 226(2): 474–83.
33de Mello, MF, Myczcowisk, LM, Menenzes, PR. A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder. J Psychother Pract Res 2001; 10(2): 117.
34Schramm, E, Schneider, D, Zobel, I, van Calker, D, Dykierek, P, Kech, S, et al. Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Aff Dis 2008; 109(1): 65–73.